Showing 1 - 13 results of 13 for search 'Ayşegül Şahin', query time: 0.05s Refine Results
  1. 1
    EVALUATION OF SENTINEL LYMPH NODES

    EVALUATION OF SENTINEL LYMPH NODES by Ayşegül Şahin

    Published 2006-01-01
    Get full text
    Article
  2. 2
    EVALUATIONS OF MARGINS

    EVALUATIONS OF MARGINS by Ayşegül Şahin

    Published 2005-01-01
    Get full text
    Article
  3. 3
    The Effect of Physical Activity Level and Sleep Quality on Quality of Life in Pregnant Women

    The Effect of Physical Activity Level and Sleep Quality on Quality of Life in Pregnant Women by Alis Kostanoğlu, Ayşe Sena Manzak, Ayşegül Şahin

    Published 2019-09-01
    Get full text
    Article
  4. 4
    Şizofrenide Psikojenik Polidipsi için Amisülpirid Tedavisi: Olgu Sunumu

    Şizofrenide Psikojenik Polidipsi için Amisülpirid Tedavisi: Olgu Sunumu by Ayşegül ŞAHİN EKİCİ, Şengül ŞAHİN, Gülçin ELBOĞA, Abdurrahman ALTINDAĞ

    Published 2019-04-01
    Get full text
    Article
  5. 5
    Bacteriological Profile and Antimicrobial Resistance Pattern Among Healthcare-Associated Infections in a Pediatric Intensive Care Unit

    Bacteriological Profile and Antimicrobial Resistance Pattern Among Healthcare-Associated Infections in a Pediatric Intensive Care Unit by Benhur Sirvan Cetin, Ayşegül Şahin, Cemile Altay Kürkçü, Fatma Küçük, Pınar Sağıroğlu, Başak Nur Akyıldız

    Published 2022-08-01
    Get full text
    Article
  6. 6
    Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma

    Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma by Harsh Batra, Qingqing Ding, Renganayaki Pandurengan, Heladio Ibarguen, Neus Bota Rabassedas, Aysegul Sahin, Ignacio Wistuba, Edwin Roger Parra, Maria Gabriela Raso

    Published 2023-12-01
    Get full text
    Article
  7. 7
    Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer.

    Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. by Patricia A Thompson, Abenaa M Brewster, Do Kim-Anh, Veerabhadran Baladandayuthapani, Bradley M Broom, Mary E Edgerton, Karin M Hahn, James L Murray, Aysegul Sahin, Spyros Tsavachidis, Yuker Wang, Li Zhang, Gabriel N Hortobagyi, Gordon B Mills, Melissa L Bondy

    Published 2011-01-01
    Get full text
    Article
  8. 8
    Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1.

    Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1. by Carolina J Jorgez, Jill A Rosenfeld, Nathan R Wilken, Hima V Vangapandu, Aysegul Sahin, Dung Pham, Claudia M B Carvalho, Anne Bandholz, Amanda Miller, David D Weaver, Barbara Burton, Deepti Babu, John S Bamforth, Timothy Wilks, Daniel P Flynn, Elizabeth Roeder, Ankita Patel, Sau W Cheung, James R Lupski, Dolores J Lamb

    Published 2014-01-01
    Get full text
    Article
  9. 9
    Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

    Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. by Priscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M Holder, Chandeshwar Sharma, Huiqin Chen, Kim-Anh Do, Emily Tarco, Mihai Gagea, Katherine A Naff, Aysegul Sahin, Asha S Multani, Dalliah M Black, Elizabeth A Mittendorf, Isabelle Bedrosian, Gordon B Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

    Published 2016-01-01
    Get full text
    Article
  10. 10
    Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

    Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. by Priscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M Holder, Chandeshwar Sharma, Huiqin Chen, Kim-Anh Do, Emily Tarco, Mihai Gagea, Katherine A Naff, Aysegul Sahin, Asha S Multani, Dalliah M Black, Elizabeth A Mittendorf, Isabelle Bedrosian, Gordon B Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

    Published 2015-01-01
    Get full text
    Article
  11. 11
    Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial

    Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial by Nour Abuhadra, Ryan Sun, Clinton Yam, Gaiane M. Rauch, Qingqing Ding, Bora Lim, Alastair M. Thompson, Elizabeth A. Mittendorf, Beatriz E. Adrada, Senthil Damodaran, Kiran Virani, Jason White, Elizabeth Ravenberg, Jia Sun, Jaihee Choi, Rosalind Candelaria, Banu Arun, Naoto T. Ueno, Lumarie Santiago, Sadia Saleem, Sausan Abouharb, Rashmi K. Murthy, Nuhad Ibrahim, Aysegul Sahin, Vicente Valero, William Fraser Symmans, Jennifer K. Litton, Debu Tripathy, Stacy Moulder, Lei Huo

    Published 2023-06-01
    Get full text
    Article
  12. 12
    Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

    Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation by Yan Xing, Nancy U. Lin, Matthew A. Maurer, Huiqin Chen, Armeen Mahvash, Aysegul Sahin, Argun Akcakanat, Yisheng Li, Vandana Abramson, Jennifer Litton, Mariana Chavez-MacGregor, Vicente Valero, Sarina A. Piha-Paul, David Hong, Kim-Anh Do, Emily Tarco, Dianna Riall, Agda Karina Eterovic, Gerburg M. Wulf, Lewis C. Cantley, Gordon B. Mills, L. Austin Doyle, Eric Winer, Gabriel N. Hortobagyi, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

    Published 2019-07-01
    Get full text
    Article
  13. 13
    PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens

    PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens by Hui Chen, Qingqing Ding, Laila Khazai, Li Zhao, Senthil Damodaran, Jennifer K. Litton, Gaiane M. Rauch, Clinton Yam, Jeffrey T. Chang, Sahil Seth, Bora Lim, Alastair M. Thompson, Elizabeth A. Mittendorf, Beatriz Adrada, Kiran Virani, Jason B. White, Elizabeth Ravenberg, Xingzhi Song, Rosalind Candelaria, Banu Arun, Naoto T. Ueno, Lumarie Santiago, Sadia Saleem, Sausan Abouharb, Rashmi K. Murthy, Nuhad Ibrahim, Mark J. Routbort, Aysegul Sahin, Vicente Valero, William Fraser Symmans, Debu Tripathy, Wei-Lien Wang, Stacy Moulder, Lei Huo

    Published 2023-08-01
    Get full text
    Article

Search Tools: